OraSure Technologies Inc/ US68554V1089 /
2024-09-04 10:00:00 PM | Chg. +0.0100 | Volume | Bid10:43:14 PM | Ask10:43:14 PM | High | Low |
---|---|---|---|---|---|---|
4.3800USD | +0.23% | 635,284 Turnover: 2.39 mill. |
4.2400Bid Size: 100 | 4.5100Ask Size: 100 | 4.4300 | 4.3300 |
GlobeNewswire
07-22
OraSure to Announce Second Quarter 2024 Financial Results and Host Earnings Call on August 6th
GlobeNewswire
04-22
OraSure to Announce First Quarter 2024 Financial Results and Host Earnings Call on May 8th
GlobeNewswire
02-13
OraSure to Announce Fourth Quarter 2023 Financial Results and Host Earnings Call on February 27th
GlobeNewswire
01-04
OraSure Technologies, Inc. Secures Strategic Distribution Rights and Invests in Sapphiros, a Next-Ge...
GlobeNewswire
2023-12-19
Aspira Women’s Health to Host R&D Day With Updates on the Development of the Company's Ovarian Cance...
GlobeNewswire
2023-11-07
OraSure Reports Q3 ‘23 Revenue of $89.2 Million; Core Revenue Grows 7% Year-over-Year
GlobeNewswire
2023-10-23
OraSure to Announce Third Quarter 2023 Financial Results and Host Earnings Call on November 7th
GlobeNewswire
2023-09-11
Aspira Women’s Health Announces Dr. Jody Berry as New Chief Scientific Officer
GlobeNewswire
2022-03-29
HOUSING WORKS & FOUNDING CHAIR JAMES HUNIFORD ANNOUNCE LINEUP OF TOP INTERIOR DESIGNERS FOR ANNUAL D...
GlobeNewswire
2022-03-22
OraSure Director Nancy Gagliano Selected to Serve as Interim Chief Executive Officer; Brings Extensi...
GlobeNewswire
2022-02-23
OraSure Technologies Reports 4Q21 Revenue of $63.6 Million; InteliSwab® Production Scales Up
GlobeNewswire
2022-02-16
OraSure Technologies, Inc. 2021 Fourth Quarter Earnings Conference Call Wednesday, February 23, 2022...
GlobeNewswire
2022-01-31
InteliSwab® COVID-19 Rapid Tests Receive U.S. FDA Authorization for Pediatric Use and Company Launch...
GlobeNewswire
2022-01-13
InteliSwab® COVID-19 Rapid Tests Detect Omicron at Same Level as Other Variants